The field of integrated drug delivery is rapidly changing. Today’s patients are empowered, knowledgeable and seeking treatment on their own terms, often outside of healthcare settings. As the pharmaceutical and biopharmaceutical industries, along with their drug development and delivery partners, respond to this shift, they also need to comply with tightening regulations aimed at improving the quality and safety of increasingly complex drugs. Tibor Hlobik of West Pharmaceutical Services Inc looks into partnering for patients.